Mode
Text Size
Log in / Sign up

Telestroke systems are consistently associated with higher thrombolysis utilization in patients with suspected strokeTelestroke Systems Linked to Higher Thrombolysis Use in Stroke Cases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that telestroke is associated with higher thrombolysis rates but does not provenly lower treatment thresholds.

This narrative review explores the role of telestroke systems in managing patients with suspected stroke, specifically focusing on thrombolysis utilization, the identification of stroke mimics, and the associated decision-making processes. The authors synthesize evidence regarding how remote consultation affects treatment workflows and clinical outcomes.

Key findings indicate that telestroke is consistently associated with greater thrombolysis utilization. While stroke mimics remain common among both evaluated and treated patients, the review notes that serious hemorrhagic complications following the thrombolysis of stroke mimics are uncommon. Notably, the authors state that current evidence does not demonstrate that telestroke lowers the thrombolysis threshold for treatment.

Several limitations are noted, including the fact that existing studies are predominantly observational and do not directly measure clinicians' diagnostic confidence or treatment thresholds. The authors suggest that higher IVT rates and the treatment of mimics may reflect improved specialist access, faster workflows, or system-level factors rather than a shift in clinical thresholds. The evidence is currently insufficient to confirm a causal shift in treatment thresholds.

How this fits prior evidence

This narrative review addresses gaps in understanding how telestroke systems influence clinical decision-making and treatment thresholds in acute stroke management. While previous coverage has established that tenecteplase matches alteplase for function and cuts door-to-needle time, this review specifically examines the systemic impact of telestroke on thrombolysis utilization. It clarifies that increased utilization may stem from improved access or workflow rather than a lower treatment threshold.

This review looked at how telestroke systems affect the treatment of patients with suspected strokes. Telestroke systems allow specialists to consult with local providers remotely. The review found that these systems are consistently linked to higher rates of thrombolysis, which is a medication used to break up blood clots in the brain.

While more patients received treatment, the review noted that stroke mimics still occur frequently in both groups. Importantly, the data did not show that telestroke systems actually lower the threshold for when a doctor decides to give thrombolysis. Instead, the higher treatment rates might be due to better access to specialists, faster workflows, or other system improvements.

Because most of the existing studies are observational, we cannot say for certain that telestroke causes these changes. The results suggest that while telestroke helps get treatment to more people, it may not be changing the underlying decision-making rules for doctors. Patients and providers should view these findings as a look at current trends rather than a proven change in medical standards.

What this means for you:
Telestroke systems are linked to more thrombolysis use, but they do not necessarily lower treatment thresholds.

Common questions

Does telestroke make it more likely that a patient gets thrombolysis?

Yes, the review found that telestroke systems are consistently associated with greater thrombolysis utilization. This means more patients in these systems received the medication used to break up blood clots. However, this may be due to better specialist access or faster workflows rather than a change in how doctors decide who is eligible for treatment.

Are there risks when treating stroke mimics with thrombolysis?

Stroke mimics are conditions that look like strokes but are not. The review found that while these mimics are common among both evaluated and treated patients, serious hemorrhagic complications after thrombolysis of these mimics are uncommon. You should talk to a doctor about specific risks for your situation.

Does telestroke change the rules for when doctors give treatment?

The current evidence does not show that telestroke systems lower the treatment threshold for thrombolysis. While more people are getting treated, the study does not prove that the criteria for giving the medication have changed. The higher rates may simply reflect better system-level factors like faster communication.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Telestroke expands access to specialist stroke care and is associated with increased use of intravenous thrombolysis (IVT). Whether this reflects improved access alone or also changes how clinicians act under diagnostic uncertainty remains unclear. To review evidence on telestroke-associated thrombolysis, stroke mimics, and decision-making, and to examine the hypothesis that telestroke may influence the practical threshold for IVT. We conducted a narrative review of studies addressing telestroke implementation, IVT utilization, stroke mimic frequency and safety, remote neurological assessment, and decision-related features of telestroke care. Evidence was synthesized around three proposed domains: risk asymmetry, information constraints and diagnostic friction, and distributed responsibility with workflow pressure. Telestroke is consistently associated with greater thrombolysis utilization, while stroke mimics remain common among both evaluated and treated patients. Serious hemorrhagic complications after thrombolysis of stroke mimics are uncommon. However, existing studies are predominantly observational and do not directly measure clinicians’ diagnostic confidence or treatment thresholds. Higher IVT rates and mimic treatment may therefore reflect improved specialist access, faster workflows, case mix, or other system-level factors rather than a lower threshold for treatment. Current evidence does not demonstrate that telestroke lowers the thrombolysis threshold. Instead, a treatment-threshold shift should be regarded as a testable hypothesis. Future studies should directly measure diagnostic confidence, estimated stroke probability, competing diagnoses, and treatment decisions to determine how telestroke influences clinical decision-making under uncertainty.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.